Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 57Neoplasms 32Colorectal Neoplasms 32Neoplasm Metastasis 31Breast Neoplasms 30Prostatic Neoplasms 29Pancreatic Neoplasms 25Ovarian Neoplasms 24Multiple Myeloma 23Recurrence 22Melanoma 22Squamous Cell Carcinoma of Head and Neck 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Lymphoma, Non-Hodgkin 17Endometrial Neoplasms 17Triple Negative Breast Neoplasms 16Lung Neoplasms 15Leukemia, Myeloid, Acute 15Glioblastoma 15Stomach Neoplasms 14Lymphoma, Large B-Cell, Diffuse 14Burkitt Lymphoma 14Advanced Solid Tumor 13Small Cell Lung Carcinoma 12Colonic Neoplasms 12Carcinoma, Renal Cell 12Lymphoma, Follicular 11Lymphoma 11Advanced Solid Tumors 11Glioma 10

Interventions

Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Neoplasms, Nerve Tissue × 30 days × Clear all
NCT07416188 2026-06-03

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Recruiting
40 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, Recurrence, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡